Steve Oberste

Centers for Disease Control and Prevention
CDC
Atlanta, GA
USA
Email: mbo2@cdc.gov

Papers:
114 Uncovering the Limitations and Possibilities of Cerebrospinal Fluid Molecular Testing for Neurologic Illnesses